Epidemiologic, immunologic and practical considerations in developing and evaluating a human hookworm vaccine

References

• Moorthy VS, Good MF, Hill AV. Malaria vaccine developments. Lancet363, 150–156 (2004).
   PubMed Web of Science ®Google Scholar
• Brodskyn C, de Oliveira CI, Barral A, Barral-Netto M. Vaccines in leishmaniasis: advances in the last 5 years. Expert Rev. Vaccines2, 705–717 (2003).
   PubMedGoogle Scholar
• Capron A, Riveau GJ, Bartley PB, McManus DP. Prospects for a schistosome vaccine. Curr. Drug Targets Immune Endocr. Metabol. Disord.2, 281–290 (2002).
   PubMedGoogle Scholar
• Hotez PJ, Zhan B, Bethony JM et al. Progress in the development of a recombinant vaccine for human hookworm disease: the human hookworm vaccine initiative. Int. J. Parasitol.33, 1245–1258 (2003).
   PubMed Web of Science ®Google Scholar
• de Silva NR, Brooker S, Hotez PJ et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol.19, 547–551 (2003).
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Brooker S, Bethony JM et al. Hookworm infection. N. Engl. J. Med.351, 799–807 (2004).
   PubMed Web of Science ®Google Scholar
• WHO. Annex Table 3, Burden of disease in DALYs by cause, sex and mortality stratum in WHO Regions, estimates for 2001. In: The World Health Report 2002, Reducing Risks, Promoting Health Life. World Health Organization, Geneva, 192–193 (2002).
   Google Scholar
• WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiases. WHO Technical Report Series 912. World Health Organization, Geneva, 2 (2002).
   Google Scholar
• Hoagland KE, Schad GA. Necator americanus and Ancylostoma duodenale: life history parameters and epidemiological implications of two sympatric hookworms of humans. Exp. Parasitol.44, 36–49 (1978).
   PubMed Web of Science ®Google Scholar
• Crompton DWT, Stephenson LS. Hookworm infection, nutritional status and productivity. In: Hookworm Disease Current Status and New Directions. Schad GA, Warren KS (Eds). Taylor and Francis, London, UK, 231–264 (1990).
   Google Scholar
• Stoltzfus RJ, Chwaya HM, Tielsch JM et al. Epidemiology of iron-deficiency anemia in Zanzibari schoolchildren: the importance of hookworms. Am. J. Clin. Nutr.65, 153–159 (1997).
   PubMed Web of Science ®Google Scholar
• Horton RJ. Benzimidoles in a wormy world. Parasitol. Today6, 106 (1990).
   PubMedGoogle Scholar
• Lacey E. Mode of action of Benzimidazoles. Parasitol. Today6, 112–115 (1990).
   PubMedGoogle Scholar
• Utzinger J, Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmaco.5, 263–286 (2004).
   PubMed Web of Science ®Google Scholar
• Bennett A, Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol. Today16, 71–74 (2000).
   PubMedGoogle Scholar
• Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology121, S113–S132 (2000).
   PubMed Web of Science ®Google Scholar
• Geerts S, Gryseels B. Anthelmintic resistance in human helminths: a review. Trop. Med. Int. Health6, 915–921 (2001).
   PubMed Web of Science ®Google Scholar
• de Silva NR. Impact of chemotherapy on the morbidity due to soil-transmitted nematodes. Acta Trop.86, 197–214 (2003).
   PubMed Web of Science ®Google Scholar
• Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv. Parasitol.58, 197–288 (2004).
   PubMed Web of Science ®Google Scholar
• Partnership for Child Development. Better health, nutrition and education for the school-aged child. Trans. R. Soc. Trop. Med. Hyg.91, 1–2 (1997).
   PubMedGoogle Scholar
• Savioli L, Stansfield S, Bundy DAP et al. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans. R. Soc. Trop. Med. Hyg.96, 577–579 (2002).
   PubMed Web of Science ®Google Scholar
• Albonico M, Smith PG, Ercole E et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans. R. Soc. Trop. Med. Hyg.89, 538–541 (1995).
   PubMed Web of Science ®Google Scholar
• Quinnell RJ, Slater AFG, Tighe P et al. Reinfection with hookworm after chemotherapy in Papua New Guinea. Parasitology106, 379–385 (1993).
   PubMed Web of Science ®Google Scholar
• Anderson RM, Medley GF. Community control of helminth infections of man by mass and selective chemotherapy. Parasitology90, 629–660 (1985).
   PubMed Web of Science ®Google Scholar
• Chan MS, Bradley M, Bundy DAP. Transmission patterns and the epidemiology of hookworm. Int. J. Epidemiol.26, 1392–1400 (1997).
   PubMedGoogle Scholar
• Tanner M, Evans D. Vaccines or drugs: complementarity is crucial. Parasitol. Today10, 196–202 (1994).
   PubMedGoogle Scholar
• Geerts S, Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin. Microbiol. Rev.13, 207–222 (2000).
   PubMed Web of Science ®Google Scholar
• de Clerq D, Sacko M, Behnke J et al. Failure of mebendazole in treatment of human hookworm infection in the southern region of Mali. Am. J. Trop. Med. Hyg.57, 25–30 (1997).
   PubMedGoogle Scholar
• Reynoldson JA, Behnke JM, Pallant LJ et al. Failure of pyrantel in treatment of human hookworm infection (Ancylostoma duodenale) in the Kimberely region of North West Australia. Acta Tropica68, 301–312 (1997).
   PubMed Web of Science ®Google Scholar
• Albonico M, Bickle Q, Ramsan M et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. WHO81, 343–352 (2003).
   PubMed Web of Science ®Google Scholar
• Horton J. Global anthelmintic chemotherapy programs: learning from history. Trends Parasitol.19, 405–409 (2003).
   PubMed Web of Science ®Google Scholar
• Bundy DAP, Chan MS, Guyatt HL. The practicality and sustainability of vaccination as an approach to parasite control. Parasitology110, S51–S58 (1995).
   Google Scholar
• Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press, Oxford, UK (1991).
   Google Scholar
• Anderson RM. The population dynamics and control of hookworm and roundworm infection. In: Population Dynamics of Infectious Diseases: Theory and Applications. Anderson RM (Ed.). Chapman and Hall, London, UK, 67–109 (1982).
   Google Scholar
• Bundy DAP, Medley GF. Immunoepidemiology of human geohelminthiasis: ecological and immunological determinants of worm burden. Parasitology104, S105–S119 (1992).
   Google Scholar
• Shapiro AE, Tukahebwa EM, Kasten J et al. Epidemiology of helminth infections and their relationship to clinical malaria in southwest Uganda. Trans. R. Soc. Trop. Med. Hyg.99, 18–24 (2005).
   PubMed Web of Science ®Google Scholar
• Basch PF. Antischistosomal vaccines: beyond the laboratory. Trans. Roy. Soc. Trop. Med. Hyg.87, 589–592 (1993).
   PubMedGoogle Scholar
• Fine PEM. Herd immunity: history, theory, practice. Epidemiol Rev.15(2), 265–302 (1993).
   PubMed Web of Science ®Google Scholar
• Loukas A, Prociv P. Immune responses in hookworm infections. Clin. Microbiol. Rev.14, 689–703 (2001).
   PubMed Web of Science ®Google Scholar
• Carr A, Pritchard DI. Antigen expression during development of the human hookworm, Necator americanus (Nematoda). Parasite Immunol.9, 219–234 (1987).
   PubMedGoogle Scholar
• Pritchard DI, Walsh EA, Quinnell RJ et al. Isotypic variation in antibody responses in a community in Papua New Guinea to larval and adult antigens during infection, and following reinfection, with the hookworm Necator americanus.Parasite Immunol.6, 617–631 (1992).
   Google Scholar
• Fulford AJC, Webster M, Ouma JH, Kimani G, Dunne DW. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today14, 23–26 (1998).
   PubMedGoogle Scholar
• Dessein AJ, Marquet S, Henri S et al. Infection and disease in human Schistosomiasis mansoni are under distinct major gene control. Microbes Infect.1, 561–567 (1999).
   PubMedGoogle Scholar
• Corrêa-Oliveira R, Golgher DB, Oliveira GC et al. Infection with Schistosoma mansoni correlates with altered immune responses to Ascaris lumbricoides and hookworm. Acta Trop.83, 123–132 (2002).
   PubMedGoogle Scholar
• Jarrett E, Bazin H. Elevation of total serum IgE in rats following helminth parasite infection. Nature251(5476), 613–614 (1974).
   PubMed Web of Science ®Google Scholar
• Pritchard DI, Quinnell RJ, Walsh EA. Immunity in humans to Necator americanus: IgE, parasite weight and fecundity. Parasite Immunol.2, 71–75 (1995).
   Google Scholar
• Pritchard DI. Atopy and helminth parasites. Int. J. Parasitol.2, 167–168 (1993).
   Google Scholar
• Pritchard DI, Brown A. Is Necator americanus approaching a mutualistic symbiotic relationship with humans? Trends Parasitol.4, 169–172 (2001)
   Google Scholar
• Boag PR, Parsons JC, Presidente PJ, Spithill TW, Sexton JL. Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum. Vet. Immunol. Immunopathol.92(1–2), 87–94 (2003).
   PubMedGoogle Scholar
• Geiger SM, Massara CL, Bethony J, Soboslay PT, Correa-Oliveira R. Cellular responses and cytokine production in post-treatment hookworm patients from an endemic area in Brazil. Clin. Exp. Immunol.2, 334–340 (2004).
   Google Scholar
• Quinnell RJ, Pritchard DI, Raiko A, Brown AP, Shaw MA. Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J. Infect. Dis.190(3), 430–438 (2004).
   PubMed Web of Science ®Google Scholar
• Maizels RM, Balic A, Gomez-Escobar N et al. Helminth parasites – masters of regulation. Immunol. Rev.201, 89–116 (2004).
   PubMed Web of Science ®Google Scholar
• Hesse M, Piccirillo CA, Belkaid Y et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol.5, 3157–3166 (2004).
   Google Scholar
• Ghosh K, Hotez PJ. Antibody-dependent reductions in mouse hookworm burden after vaccination with Ancylostoma caninum secreted protein 1. J. Infect. Dis.5, 1674–1681 (1999).
   Google Scholar
• Girod N, Brown A, Pritchard DI, Billett EE. Successful vaccination of BALB/c mice against human hookworm (Necator americanus): the immunological phenotype of the protective response. Int. J. Parasitol.1, 71–80 (2003).
   Google Scholar
• Wilson AR, Coulson PS. Strategies for a schistosome vaccine: can we manipulate the immune response effectively? Microbes Infect.1, 535–543 (1999).
   PubMedGoogle Scholar
• Elias D, Wolday D, Akuffo H et al. Effect of deworming on human T-cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacillus Calmette–Guerin (BCG) vaccination. Clin. Exp. Immunol.123, 219–225 (2001).
   PubMed Web of Science ®Google Scholar
• Chow SC, Brown A, Pritchard D. The human hookworm pathogen Necator americanus induces apoptosis in T-lymphocytes. Parasite Immunol.1, 21–29 (2000).
   Google Scholar
• Culley FJ, Brown A, Conroy DM et al. Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo.J. Immunol.11, 6447–6453 (2000).
   Google Scholar
• Hsieh GC, Loukas A, Wahl AM et al. A secreted protein from the human hookworm Necator americanus binds selectively to NK cells and induces IFN-g production. J. Immunol.173(4), 2699–2704 (2004).
   PubMed Web of Science ®Google Scholar
• Hawdon JM, Hotez PJ. Hookworm: developmental biology of the infectious process. Curr. Opin. Genet. Dev.6, 618–623 (1996).
   PubMedGoogle Scholar
• Loukas A, Constant SL, Bethony JM. Immunobiology of hookworm infection. FEMS Microrev. (2005).
   Google Scholar
• Maizels RM, Holland MJ, Falcone FH, Zang XX, Yazdanbakhsh M. Vaccination against helminth parasites – the ultimate challenge for vaccinologists? Immunol. Rev.171, 125–147 (1999).
   PubMed Web of Science ®Google Scholar
• Bungiro RD, Green J, Kruglov E, Cappello M. Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylanicum. J. Infect. Dis.183, 1380–1387 (2001).
   PubMedGoogle Scholar
• Allen JE, MacDonald AS. Profound suppression of cellular proliferation mediated by the secretions of nematodes. Parasite Immunol.20, 241–247 (1998).
   PubMedGoogle Scholar
• Miller TA. Industrial development and field use of the canine hookworm vaccine. Adv. Parasitol.16, 333–342 (1978).
   PubMedGoogle Scholar
• Hotez PJ, Ghosh K, Hawdon JM et al. Experimental approaches to the development of a recombinant hookworm vaccine. Immunol. Rev.171, 163–171 (1999).
   PubMed Web of Science ®Google Scholar
• Hawdon JM, Narasmihan S, Hotez PJ. Ancylostoma secreted protein 2: cloning and characterization of a second member of a family of nematode-secreted proteins from Ancylostoma caninum. Mol. Biochem. Parasitol.30, 149–165 (1999).
   Google Scholar
• Goud GN, Zhan B, Ghosh K et al. Cloning, yeast expression, isolation and vaccine testing of recombinant Ancylostoma-secreted protein 1 (ASP-1) and ASP-2 from Ancylostoma ceylanicum. J. Infect. Dis.189, 919–929 (2004).
   PubMedGoogle Scholar
• Mendez S, Zhan B, Goud G et al. Effect of combining the larval antigens Ancylostoma-secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum. Vaccine (2005) (In Press).
   Google Scholar
• Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Buss P. Hookworm – the great infection of mankind. PLoS Medicine (2005) (In Press).
   Google Scholar
• Zhan B, Wang Y, Liu YY et al. Ac-SAA-1 an immunodominant 16-kDa surface-associated antigen of infective larvae and adults of Ancylostoma caninum. Int. J. Parasitol.34, 1037–1045 (2004).
   PubMedGoogle Scholar
• Zhan B, Hotez PJ, Wang Y, Hawdon J. A developmentally regulated metalloprotease secreted by host stimulated Ancylostoma caninum third-stage infective larvae is a member of the astacin family of proteases. Mol. Bio. Parasitol.120, 291–296 (2002).
   PubMedGoogle Scholar
• Williamson AL, Lecchi P, Turk BE et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J. Bio. Chem.279, 35950–35957 (2004).
   PubMedGoogle Scholar
• Williamson AL, Brindley PJ, Knox, DP, Hotez PJ, Loukas A. Digestive proteases of blood-feeding nematodes and other parasites. Trends Parasitol.19, 417–423 (2003).
   PubMedGoogle Scholar
• Loukas A, Bethony JM, Williamson AL et al. Vaccination of dogs with recombinant cysteine protease from the intestine of canine hookworms diminishes fecundity and growth of worms. J. Infect. Dis.189, 1952–1961 (2004).
   PubMedGoogle Scholar
• Williamson AL, Lecchi P, Turk BE et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J. Biol. Chem.279, 35950–35957 (2004).
   PubMedGoogle Scholar
• Jones BF, Hotez PJ. Molecular cloning and characterization of Ac-mep-1, a developmentally regulated gut luminal metalloendopeptidase from adult Ancylostoma caninum hookworms. Mol. Biochem. Parasitol.119, 107–116 (2002).
   PubMedGoogle Scholar
• Orenstein WA, Bernier RH, Hinman AJ. Assessing vaccine efficiency in the field. Epidemiol. Rev.10, 212–241 (1988).
   PubMed Web of Science ®Google Scholar
• Smith PG. Evaluating interventions against tropical diseases. Int. J. Epidemiol.16, 159–166 (1987).
   PubMed Web of Science ®Google Scholar
• Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA275, 390–397 (1996).
   PubMed Web of Science ®Google Scholar
• Jaffar S, Leach A, Hall AJ et al. Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation? Vaccine18, 633–640 (2000).
   Google Scholar
• Hayes RJ, Alexander ND, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stats. Methods Med. Res.9(2), 95–116 (2000).
   PubMed Web of Science ®Google Scholar
• Todd CW, Colley DG. Practical and ethical issues in the development of a vaccine against Schistosomiasis mansoni. Am. J. Trop. Med. Hyg.66, 348–358 (2002).
   PubMedGoogle Scholar
• Booth M, Vounatsou P, N’goran EK, Tanner M, Utzinger J. The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm coinfections in rural Cote d’Ivoire. Parasitology127, 525–531 (2003).
   PubMedGoogle Scholar
• Stoltzfus R J, Albonico M, Chwaya HM et al. Hemoquant determination of hookworm-related blood loss and its role in iron deficiency in African children. Am. J. Trop. Med. Hyg.55(4), 399–404 (1996).
   PubMed Web of Science ®Google Scholar
• Bradley M, Chandiwana SK, Bundy DAP, Medley GF. The epidemiology and population biology of Necator americanus infection in a rural community in Zimbabwe. Trans. R. Soc. Trop. Med. Hyg.86, 73–76 (1992).
   PubMed Web of Science ®Google Scholar
• Roche M, Layrisse M. The nature and causes of hookworm anemia. Am. J. Trop. Med. Hyg.15, 1031–110 (1966).
   Web of Science ®Google Scholar
• Guyatt HL. The economics of worm control. In: The Geohelminths. Ascaris, Trichuris and Hookworm. Holland CV, Kennedy MW (Eds). Kluwer Academic Publishers, Boston, USA, 75–87 (2001).
   Google Scholar
• Beutels P, van Doorslaer E, van Damme, Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev. Vaccines2, 89–100 (2003).
   Google Scholar
• Guyatt HL, Evans D. Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis. Acta Tropica59, 197–209 (1995).
   PubMedGoogle Scholar
• Chan MS, Woolhouse, MEJ, Bundy DAP. Human schistosomiasis: potential long term consequences of vaccination programs. Vaccine15, 1545–1550 (1997).
   PubMed Web of Science ®Google Scholar
• Graves PM. Comparison of the cost effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria. Ann. Trop. Med. Parasitol.92, 399–410 (1998).
   PubMed Web of Science ®Google Scholar
• Gryseels B. Schistosomiasis vaccines: a devil’s advocate view. Parasitol. Today16, 46–48 (2000).
   PubMedGoogle Scholar
• Boily MC, Masse BR, Desai K, Alary M, Anderson RM. Some important issues in the planning of Phase III HIV vaccine efficacy trials. Vaccine17, 989–1004 (1999).
   PubMed Web of Science ®Google Scholar
• Williams GM, Sleigh AC, Li Y et al. Mathematical modeling of Schistosomiasis japonica: comparison of control strategies in the People’s Republic of China. Acta Trop.82, 253–262 (2002).
   PubMed Web of Science ®Google Scholar
• Chan MS, Guyatt HL, Bundy DAP, Medley GF. The development and validation of an age-stratified model for the evaluation of disease control strategies for intestinal helminths. Parasitology109, 389–396 (1994).
   PubMedGoogle Scholar
• McCullagh P, Nelder JA. Generalized Linear Models. Chapman and Hall/CRC, London, UK (1989).
   Google Scholar
• Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th Edition. Blackwell Scientific Publications, Oxford, UK (2001).
   Google Scholar
• Krebs CJ. Ecological Methodology. 2nd Edition. Harlow. Benjamin/Cummings, CA, USA (1999).
   Google Scholar
• Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control. Clin. Trials2, 93–113 (1981).
   PubMedGoogle Scholar